Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.

NCT ID: NCT04910607

Last Updated: 2024-01-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

279 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-01-21

Study Completion Date

2023-07-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The population suffering from obesity is particularly at risk during this pandemic period. The Nouvelle Aquitaine region is not spared, since according to the regional epidemiological report of 7 May 2020, carried out by Santé Publique France, 39.2% of cases admitted to the intensive care unit in Nouvelle Aquitaine and presenting risk factors are overweight or obese.

Other risk factors, such as social-environmental factors, must be taken into consideration. Socio-demographic surveys in this area highlight the socio-economic and territorial inequalities that interfere with obesity issues. Similarly, the issues of stigmatisation and isolation seem to be at the heart of the question of how to deal with these people.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective multicentre study. Participating patients will be recruited from the Specialised Obesity Centres (CHU and SSR, as well as patient associations) to fill in a questionnaire and take part in an interview (a varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age).

The medical and paramedical staff involved in the partner CSOs and the patients' resources (identified by the patients' associations) will also be asked to participate in a semi-directive interview.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Covid19

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patient

Participating patients will be recruited from the Specialised Obesity Centres =CSO (CHU and Follow-up and rehabilitation care (SSR), as well as patient associations) to fill in a questionnaire and take part in an interview (varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age).

Questionnaire

Intervention Type OTHER

Questionnaire with 4 axes:

sociological, reflexive medical, prospective medical, transversal

Interview

Intervention Type OTHER

Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.

Professional

Medical and paramedical staff involved in the partner CSOs will also be asked to participate in a semi-structured interview.

Interview

Intervention Type OTHER

Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

Questionnaire with 4 axes:

sociological, reflexive medical, prospective medical, transversal

Intervention Type OTHER

Interview

Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients 18 years of age.
* Be registered in an active file of the 3 partner CSOs.

Exclusion Criteria

* Patients under 18 years of age.
* Patients under protective measures or deprived of liberty:

* pregnant or breastfeeding woman,
* under guardianship,
* under guardianship,
* safeguard of justice,
* incarcerated.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Région Nouvelle Aquitaine

UNKNOWN

Sponsor Role collaborator

University Hospital, Bordeaux

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arnaud ALESSANDRIN, Dr

Role: STUDY_CHAIR

Universite de Bordeaux

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de Limoges

Limoges, , France

Site Status

Hôpital Haut-Lévêque

Pessac, , France

Site Status

CHU de Poitiers

Poitiers, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CHUBX 2020/38

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.